“Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial”, J of Skin, vol. 4, no. 6, p. s99, Oct. 2020, doi: 10.25251/skin.4.supp.99.